Literature summary for 3.4.22.69 extracted from

Rahman, M.; Hosen, M.; Howlader, M.; Kabir, Y.
Lead molecule prediction and characterization for designing MERS-CoV 3C-like protease inhibitors An in silico approach (2019), Curr. Comput. Aided Drug Des., 15, 82-88 .

Search for more literature for 3.4.22.69

Organism

Organism	UniProt	Comment	Textmining
Middle East respiratory syndrome-related coronavirus	-	-	-

Synonyms

Synonyms	Comment	Organism
MERS-CoV 3C-like protease	-	Middle East respiratory syndrome-related coronavirus

General Information

General Information	Comment	Organism
drug target	prediction of lead molecules which are capable of inhibiting 3C-like protease, and thus inhibit the lifecycle of Middle East Respiratory Syndrome Coronavirus using in silico methods. Detection of potential drugs by structure-based virtual screening and ligand-based virtual screening approach	Middle East respiratory syndrome-related coronavirus
physiological function	essential enzyme for the completion of the life cycle of Middle East Respiratory Syndrome Coronavirus	Middle East respiratory syndrome-related coronavirus

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)